Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
1.000
-0.020 (-1.96%)
At close: Feb 21, 2025, 4:00 PM
0.964
-0.036 (-3.59%)
After-hours: Feb 21, 2025, 6:02 PM EST
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $60.34 million as of February 21, 2025. Its market cap has decreased by -5.07% in one year.
Market Cap
60.34M
Enterprise Value
-38.72M
1-Year Change
-5.07%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $60.34M, a decrease of -93.98%. That is a compound annual growth rate of -47.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 60.34M | 5.26% |
| Dec 31, 2024 | 57.32M | -21.36% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |